Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) |
| BNF code | 0601023Y0BCABAD |
| Virtual Medicinal Product | Exenatide 2mg powder and solvent for prolonged-release suspension for injection pre-filled disposable devices |
| Name | Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens |
| Abbreviated name | Bydureon 2mg inj pre-filled pens |
| Date of name applicability | 26 Feb 2020 |
| Previous name | Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pen |
| Supplier | AstraZeneca UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Not available |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.